Statistics
Total Visits
Views | |
---|---|
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group | 117 |
Total Visits Per Month
February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | |
---|---|---|---|---|---|---|---|
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group | 1 | 2 | 1 | 5 | 3 | 2 | 0 |
Top country views
Views | |
---|---|
Poland | 54 |
United States | 45 |
Ireland | 4 |
Sweden | 3 |
France | 2 |
India | 2 |
Russia | 2 |
Argentina | 1 |
Australia | 1 |
Canada | 1 |
Top cities views
Views | |
---|---|
Warsaw | 54 |
Louisville | 10 |
San Ramon | 8 |
Boardman | 5 |
Des Moines | 4 |
Dublin | 4 |
Mountain View | 4 |
San Diego | 3 |
San Mateo | 3 |
Ann Arbor | 2 |